A Quantitative Evaluation of COVID-19 Epidemiological Models.

COVID-19 Epidemiology Forecasting Modeling Scoring

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
08 Feb 2021
Historique:
pubmed: 11 2 2021
medline: 11 2 2021
entrez: 10 2 2021
Statut: epublish

Résumé

Quantifying how accurate epidemiological models of COVID-19 forecast the number of future cases and deaths can help frame how to incorporate mathematical models to inform public health decisions. Here we analyze and score the predictive ability of publicly available COVID-19 epidemiological models on the COVID-19 Forecast Hub. Our score uses the posted forecast cumulative distributions to compute the log-likelihood for held-out COVID-19 positive cases and deaths. Scores are updated continuously as new data become available, and model performance is tracked over time. We use model scores to construct ensemble models based on past performance. Our publicly available quantitative framework may aid in improving modeling frameworks, and assist policy makers in selecting modeling paradigms to balance the delicate trade-offs between the economy and public health.

Identifiants

pubmed: 33564783
doi: 10.1101/2021.02.06.21251276
pmc: PMC7872378
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB021711
Pays : United States

Auteurs

Osman N Yogurtcu (ON)

Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US FDA, 10903 New Hampshire Ave, Silver Spring, 20993, Maryland, USA.

Marisabel Rodriguez Messan (MR)

Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US FDA, 10903 New Hampshire Ave, Silver Spring, 20993, Maryland, USA.

Richard C Gerkin (RC)

School of Life Sciences, Arizona State University, Tempe, 85287, Arizona, USA.

Artur A Belov (AA)

Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US FDA, 10903 New Hampshire Ave, Silver Spring, 20993, Maryland, USA.

Hong Yang (H)

Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US FDA, 10903 New Hampshire Ave, Silver Spring, 20993, Maryland, USA.

Richard A Forshee (RA)

Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US FDA, 10903 New Hampshire Ave, Silver Spring, 20993, Maryland, USA.

Carson C Chow (CC)

Mathematical Biology Section, NIDDK/LBM, NIH, Bethesda, 20892, Maryland, USA.

Classifications MeSH